JP2023532681A5 - - Google Patents

Info

Publication number
JP2023532681A5
JP2023532681A5 JP2022580239A JP2022580239A JP2023532681A5 JP 2023532681 A5 JP2023532681 A5 JP 2023532681A5 JP 2022580239 A JP2022580239 A JP 2022580239A JP 2022580239 A JP2022580239 A JP 2022580239A JP 2023532681 A5 JP2023532681 A5 JP 2023532681A5
Authority
JP
Japan
Prior art keywords
xyl
rha
fuc
saponin
glc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022580239A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023532681A (ja
Filing date
Publication date
Priority claimed from PCT/EP2020/071045 external-priority patent/WO2021014019A1/en
Application filed filed Critical
Priority claimed from PCT/EP2021/067227 external-priority patent/WO2021260054A2/en
Publication of JP2023532681A publication Critical patent/JP2023532681A/ja
Publication of JP2023532681A5 publication Critical patent/JP2023532681A5/ja
Pending legal-status Critical Current

Links

JP2022580239A 2020-06-24 2021-06-23 改善された治療濃度域を有するサポニン誘導体 Pending JP2023532681A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
NL2025904 2020-06-24
NL2025904 2020-06-24
EPPCT/EP2020/071045 2020-07-24
PCT/EP2020/071045 WO2021014019A1 (en) 2019-07-25 2020-07-24 Saponin derivatives with improved therapeutic window
PCT/EP2021/067227 WO2021260054A2 (en) 2020-06-24 2021-06-23 Saponin derivatives with improved therapeutic window

Publications (2)

Publication Number Publication Date
JP2023532681A JP2023532681A (ja) 2023-07-31
JP2023532681A5 true JP2023532681A5 (cg-RX-API-DMAC10.html) 2024-06-27

Family

ID=79282018

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022580237A Pending JP2023532680A (ja) 2020-06-24 2021-06-23 改善された治療濃度域を有するサポニン誘導体
JP2022580239A Pending JP2023532681A (ja) 2020-06-24 2021-06-23 改善された治療濃度域を有するサポニン誘導体

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022580237A Pending JP2023532680A (ja) 2020-06-24 2021-06-23 改善された治療濃度域を有するサポニン誘導体

Country Status (10)

Country Link
US (2) US20230277612A1 (cg-RX-API-DMAC10.html)
EP (2) EP4171639A2 (cg-RX-API-DMAC10.html)
JP (2) JP2023532680A (cg-RX-API-DMAC10.html)
KR (2) KR20230043113A (cg-RX-API-DMAC10.html)
CN (2) CN116615249A (cg-RX-API-DMAC10.html)
AU (2) AU2021295292A1 (cg-RX-API-DMAC10.html)
CA (2) CA3184027A1 (cg-RX-API-DMAC10.html)
IL (2) IL299358A (cg-RX-API-DMAC10.html)
MX (1) MX2022016485A (cg-RX-API-DMAC10.html)
WO (2) WO2021260054A2 (cg-RX-API-DMAC10.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4117730A1 (en) * 2020-06-24 2023-01-18 Sapreme Technologies B.V. Conjugate of saponin and single-domain antibody, pharmaceutical composition comprising said conjugate, therapeutic use thereof
WO2024005485A1 (ko) * 2022-06-26 2024-01-04 기초과학연구원 사포닌 유도체 화합물 및 이를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학적 조성물
KR102887798B1 (ko) * 2022-06-26 2025-11-18 기초과학연구원 사포닌 유도체 화합물 및 이를 포함하는 코로나바이러스 감염증의 예방 또는 치료용 약학적 조성물
WO2026087695A1 (en) 2024-10-24 2026-04-30 Sapreme Technologies B.V. Treatment for metabolic disorder
CN119423084B (zh) * 2024-11-07 2025-10-24 四川省烟草公司攀枝花市公司 川续断皂苷乙在蚜虫防治中的应用及杀蚜剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5583112A (en) 1987-05-29 1996-12-10 Cambridge Biotech Corporation Saponin-antigen conjugates and the use thereof
US5273965A (en) * 1992-07-02 1993-12-28 Cambridge Biotech Corporation Methods for enhancing drug delivery with modified saponins
US5650398A (en) * 1992-07-02 1997-07-22 Cambridge Biotech Corporation Drug delivery enhancement via modified saponins
WO1996008274A2 (en) * 1994-09-13 1996-03-21 Prizm Pharmaceuticals, Inc. Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents
AU710309B2 (en) * 1995-05-16 1999-09-16 Selective Genetics, Inc. Compositions containing nucleic acids and ligands for therapeutic treatment
US6080725A (en) * 1997-05-20 2000-06-27 Galenica Pharmaceuticals, Inc. Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof
NZ500779A (en) * 1997-05-20 2001-06-29 Galenica Pharmaceuticals Inc Triterpene saponin analogs having adjuvant and immunostimulatory activity
US7727561B2 (en) * 2001-08-31 2010-06-01 Pacific Arrow Limited Composition comprising Xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof
AU2002350181A1 (en) * 2001-10-31 2003-05-12 Corixa Corporation Compositions and methods for viral delivery
WO2003069997A1 (en) * 2002-02-04 2003-08-28 Corixa Corporation Immunostimulant compositions comprising aminoalkyl glucosaminide phosphates and saponins
CA2522213A1 (en) * 2003-04-08 2004-10-28 Dante J. Marciani Semi-synthetic saponin analogs with carrier and immune stimulatory activities for dna and rna vaccines
ES2395818T3 (es) * 2004-07-13 2013-02-15 Charite - Universitatsmedizin Berlin Composición que comprende un agente farmacológicamente activo acoplado a un componente específico de célula diana, y una saponina
WO2009143345A2 (en) * 2008-05-22 2009-11-26 University Of Massachusetts Nucleic acid silencing agent-protein conjugates and use thereof for treating hcv-related disorders
WO2014163558A1 (en) * 2013-04-01 2014-10-09 Moreinx Ab Nanoparticles, composed of sterol and saponin from quillaja saponaria molina process for preparation and use thereof as carrier for amphipatic of hydrphobic molecules in fields of medicine including cancer treatment and food related compounds
KR102522346B1 (ko) * 2013-08-29 2023-04-17 시티 오브 호프 세포침투 콘주게이트 및 이의 사용 방법
WO2015184451A1 (en) 2014-05-30 2015-12-03 Memorial Sloan-Kettering Cancer Center Minimal saponin analogues, synthesis and use thereof
EP3356371A4 (en) * 2015-09-29 2020-06-24 The University of Chicago POLYMER CONJUGATE VACCINE
WO2017190020A1 (en) * 2016-04-28 2017-11-02 The Scripps Research Institute Oligonucleotide conjugates and uses thereof
WO2018100558A2 (en) * 2016-12-01 2018-06-07 Takeda Pharmaceutical Company Limited Cyclic dinucleotide
EP3652190B1 (en) * 2017-07-11 2023-06-14 Freie Universität Berlin Novel uses of a saponin and method for its isolation
US20220023433A1 (en) * 2018-12-21 2022-01-27 Sapreme Technologies B.V. Saponin Conjugates
EP4003425A2 (en) * 2019-07-25 2022-06-01 Sapreme Technologies B.V. Bioactive saponin linked to a functional moiety
BR112022001389A8 (pt) * 2019-07-25 2023-04-25 Univ Berlin Charite Derivados de saponina com janela terapêutica melhorada

Similar Documents

Publication Publication Date Title
JP2022542075A5 (cg-RX-API-DMAC10.html)
Chen et al. Voglibose (Basen®, AO-128), one of the most important α-glucosidase inhibitors
US5017566A (en) Redox systems for brain-targeted drug delivery
US11021506B2 (en) Thiosaccharide mucolytic agents
WO2011075953A1 (zh) 多臂聚乙二醇衍生物及其与药物的结合物和凝胶
TWI326687B (en) Amide prodrug of gemcitabine, compositions and use thereof
CA2556169A1 (en) Use of amino-oxy functional groups in the preparation of vaccines
WO2010060260A1 (zh) 新型的多臂聚乙二醇及其制备方法和应用
HUP0302269A2 (hu) Hipokoleszterinémiás szerekként alkalmazható cukor-szubsztituált 2-azetidinonok
JP2000516224A (ja) 修飾オリゴサッカライド
US7812006B2 (en) Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide
CN108350014A (zh) 氨基糖苷衍生物及其在治疗遗传性病症中的应用
JP2018528211A5 (cg-RX-API-DMAC10.html)
MX2022016485A (es) Derivados de saponina con ventana terapeutica mejorada.
CA2272701C (en) Glycolipid mimics and methods of use thereof
JPH11508564A (ja) 合成n−結合グリココンジュゲートを製造するための方法
US7582737B2 (en) Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharides
US20240299554A1 (en) Prodrugs with 1-(disulfanyl)alkyloxy-carbonyl units
JP2005041817A (ja) クルクミノイド配糖体、及びその製造方法
JP2001500901A (ja) 抗腫瘍および駆虫剤を溶解するために特に利用されるチオウレイド―シクロデキストリン、およびその製造方法
US20070021380A1 (en) Novel drug delivery compositions
CN111593080B (zh) 一种α-半乳糖抗原活性前体及其合成方法和应用
JP2023533693A5 (cg-RX-API-DMAC10.html)
JP2023542500A5 (cg-RX-API-DMAC10.html)
JP2000191685A (ja) コレスタノール化合物及びこれを含有する医薬